Professor Heather Payne

Professor Heather Payne

MBBS, FRCP, FRCR

Oncology

Offers video consultation
Recommended by 1 specialist
39 years of experience
25 years as a specialist

Overall Rating

Overall Experience

5

Bedside Manner

5

Explanation

5

Top feedback

“Right from the outset Professor Payne was so reassuring and explained everything in layman’s language that made it all clear.and easily understandable. I could not have possibly been in more capable hands.“
Read more

Subspecialties

  • Prostate Cancer
  • Clinical Oncology
  • Medical Oncology
Show more

Languages spoken

  • English
Show more

Registered with

  • General Medical Council: 2822301
Show more

    Consultation fees

    New appointment: £300

    Follow-up appointment: £200

    Practices worked at

    The Harley Street Clinic

    35 Weymouth Street, london, United Kingdom, W1G 8BJ
    1,827 reviews

    The Prostate Centre

    18 Devonshire Street, London, United Kingdom, W1G 7AQ
    306 reviews

    LOC at Chelsea

    102 Sydney Street, Chelsea, London, United Kingdom, SW3 6NJ
    2 reviews

    About

    Professor Heather Payne, Consultant Clinical Oncologist, is currently working within the University College London Hospitals NHS Trust, she also sees patients in a private capacity at The Harley Street Clinic and The Prostate Centre. She is highly specialised in the treatment of urological and prostate cancers.

    Professor Heather Payne qualified in medicine from St Mary’s Hospital and focused on general medicine after her graduation working in both London and Haiti. After her time abroad she returned to London, where she trained in clinical oncology, and established her interest in urological oncology.

    Miss Payne is also an active researcher, where she developed a new treatment plan of high-dose-rate brachytherapy for prostate cancer. Her current research focuses on hormone therapy, sensitisation of hormones and radiotherapy, predictive indices for bowel toxicity with radiotherapy, and treatment and decision making in prostate cancer. She has held the position of Principal Investigator in several high-profile clinical studies and has a significant publication history. Furthermore, She holds the position of chair for the National Prostate Cancer Audit and is on the advisory board for the Prostate Cancer Advisory Group for the UK. 

    Procedures

    • Hormone Therapy
    • Chemotherapy
    • Image Guided Radiotherapy (IGRT)
    • Radiotherapy
    • RapidArc or Volume Modulated Arc Therapy (VMAT)
    Read more

    Special interests

    • Prostate Cancer
    Read more

    Education

    • MB BS 1983 University of London
    • FRCP
    • FRCR
    • Chair in Prostate Oncology August 2015 - University College London
    Read more

    Reviews

    5 Overall Patient Trust rating
    Overall Experience
    5
    Bedside Manner
    5
    Explanation
    5
    Prostate Cancer
    36/36
    Clinical Oncology
    3/36
    Hormone Therapy
    3/36
    Chemotherapy
    2/36
    Image Guided Radiotherapy (IGRT)
    1/36
    Medical Oncology
    1/36
    Radiotherapy
    1/36
    Read more
    Sort by:
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Right from the outset Professor Payne was so reassuring and explained everything in layman’s language that made it all clear.and easily understandable. I could not have possibly been in more capable hands.
    Read more
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Patient seen for:
    Professor Payne made immediate contact in a warm and empathetic manner, explaining all the results and the treatment plan a simple and very clearly understandable way. She was superb in all aspects of her consultations
    Read more
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Fifteen years now - she is so kind and sensitive as well as being a world-leader in her field
    Read more
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Patient seen for:
    I have been a patient of Professor Payne for some ten years . I have been very satisfied with the caring and detailed approach from Professor Payne . Never rushed , every stage carefully explained.and advised
    Read more
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Extremely caring lady. Made me feel very special. Full of knowledge and I have all the confidence in her management and guidance. A lovely person and I’m very grateful to be under Prof Heather Payne.
    Read more
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Patient seen for:
    Exceptional
    Read more
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Comforting, affable demeanor, excellent clinical acumen and etiquette
    Read more
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Patient seen for:
    The patient feels really confident under Prof Payne's supervision
    Read more
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Prof Payne is not only knowledgeable and experienced in her field, she is a kind, approachable and a compassionate person. She carefully explained in detailed all aspects of the disease and treatment options and patiently answered all our questions. We left the consultation feeling more reassured and knowledgeable. It was such a pleasure to meet her and would highly recommend her.
    Read more
    Overall Experience (5/5)
    Bedside Manner (5/5)
    Explanation (5/5)
    Patient seen for:
    I’ve been very much reassured about my treatment plan since meeting and discussing with Prof Payne. She’s been empathetic and quite clear in all communication.
    Read more
    Other Reviews

    Peer recommendations

    Recommended by 1 specialist
    Professor Greg Shaw
    Professor Greg Shaw
    Urology
    Is a colleague

    "Heather is a brilliant colleague and is exceptionally caring to her patients. Heather always gives a very careful balanced opinion."

    05-10-2021

    Recommended for:
    Urological Cancers, Adenocarcinoma

    Insurers